Gilder Gagnon Howe & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$55.6M |
| 2 |
Allegion
ALLE
|
+$47.1M |
| 3 |
Illumina
ILMN
|
+$43.8M |
| 4 |
Nike
NKE
|
+$42.7M |
| 5 |
lululemon athletica
LULU
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$103M |
| 2 |
OPEN
OPENTABLE,INC COMMON STOCK
OPEN
|
+$68M |
| 3 |
MON
Monsanto Co
MON
|
+$60.2M |
| 4 |
EQT Corp
EQT
|
+$46.5M |
| 5 |
Yelp
YELP
|
+$46.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 19.86% |
| 2 | Healthcare | 19.72% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 8.36% |
Similar funds
Gilder Gagnon Howe & Co's Q3 2014 Portfolio in Review
As of Q3 2014, Gilder Gagnon Howe & Co held 341 positions worth $6.88B, down 8.8% from $7.54B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Gilder Gagnon Howe & Co withdrew a net $589M in Q3 2014, closing 48 positions and reducing 163 holdings. Its most notable exit was OPENTABLE,INC COMMON STOCK, an estimated $68M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Gilder Gagnon Howe & Co opened a new position in Allegion worth $42.8M.
- Gilder Gagnon Howe & Co's largest Q3 2014 buy was Allegion: 899,388 shares worth $42.8M.
- Gilder Gagnon Howe & Co added most to Twitter, Inc. in Q3 2014, an estimated $55.6M increase.
- Gilder Gagnon Howe & Co's biggest Q3 2014 reduction was Boston Scientific, cutting an estimated $103M.
- Gilder Gagnon Howe & Co fully exited OPENTABLE,INC COMMON STOCK in Q3 2014, selling an estimated $68M.
- Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $6.88B portfolio in Q3 2014.
- Gilder Gagnon Howe & Co opened 35 new positions and closed 48 in Q3 2014.
- Gilder Gagnon Howe & Co's portfolio value fell 8.8% quarter-over-quarter to $6.88B.
Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2014, filed 13 Nov 2014.